据美国食品药品管理局（FDA）消息，2月22日美国FDA发布关于亚麻酸（ALA）、二十碳五烯酸（EPA）和二十二碳六烯酸（DHA）Ω-3脂肪酸等多不饱和脂肪酸标识要求的小型企业合规指南，并自2月23日起征求意见。
2014年4月28日，美国联邦公报刊登关于三种不饱和脂肪酸的营养声称标识要求，条例于2016年1月1日起生效。条例禁止食品（包含食品补充剂）标识声称“富含”（及其类似语）DHA或EPA，同时禁止亚麻酸的部分类似声称。
部分原文报道如下：
he U.S. Food and Drug Administration is announcing the availability of a Small Entity Compliance Guide （SECG） to help small entities （food companies） comply with FDA's final rule that addressed specific nutrient content claims for Omega-3 fatty acids. The SECG restates the requirements of the final rule in a plain language question and answer format.
The final rule “Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids,” which was published in the Federal Register on April 28, 2014 and became effective January 1, 2016, prohibits claims that a food is “high in” DHA or EPA. Synonyms such as “rich in” and “excellent source of” DHA or EPA are also prohibited. The final rule also prohibits some such claims for ALA, but takes no action with respect to other such claims for ALA.
原文链接：http://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm484395.htm
日期：2016-02-24
